Zobrazeno 1 - 9
of 9
pro vyhledávání: '"G J, Kolvenbag"'
Autor:
D G, McLeod, P F, Schellhammer, N J, Vogelzang, M S, Soloway, R, Sharifi, N L, Block, P M, Venner, A L, Patterson, M F, Sarosdy, R P, Kelley, G J, Kolvenbag
Publikováno v:
The Prostate. 40(4)
Black race has been associated with a significantly increased risk of prostate cancer mortality. This exploratory analysis investigated the effect of race on the clinical outcome of combined androgen blockade (CAB).Data for analysis were obtained fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5221869647ae06a92708dd9d4beacf9c
https://pubmed.ncbi.nlm.nih.gov/10420149
https://pubmed.ncbi.nlm.nih.gov/10420149
Autor:
G J, Kolvenbag, A, Nash
Publikováno v:
The Prostate. 39(1)
Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::75ac6b38c6e1213f1ded254068367948
https://pubmed.ncbi.nlm.nih.gov/10221266
https://pubmed.ncbi.nlm.nih.gov/10221266
Publikováno v:
The Prostate. 34(1)
Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00d52b77d0add40ac7406df5ecbb270c
https://pubmed.ncbi.nlm.nih.gov/9428389
https://pubmed.ncbi.nlm.nih.gov/9428389
Autor:
G J, Kolvenbag, B J, Furr
Publikováno v:
The cancer journal from Scientific American. 3(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55f637eff4f497b2a49c454cccc8317d
https://pubmed.ncbi.nlm.nih.gov/9263624
https://pubmed.ncbi.nlm.nih.gov/9263624
Autor:
P F, Schellhammer, P, Venner, G P, Haas, E J, Small, P T, Nieh, D R, Seabaugh, A L, Patterson, E, Klein, Z, Wajsman, B, Furr, Y, Chen, G J, Kolvenbag
Publikováno v:
The Journal of urology. 157(5)
We determined whether decreases in prostate specific antigen (PSA) would occur after withdrawal of double-blinded antiandrogen therapy with flutamide or bicalutamide for clinical progression or increasing PSA concentration in patients receiving combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa8c11db707a4027c0e62250c5367fcb
https://pubmed.ncbi.nlm.nih.gov/9112515
https://pubmed.ncbi.nlm.nih.gov/9112515
Publikováno v:
Urology. 48(6)
To compare the pharmacodynamics and tolerability of the new goserelin acetate 10.8-mg depot with the 3.6-mg depot in patients with advanced prostate cancer during the first 3 months of therapy.One hundred sixty patients were randomized in two compara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d150669d58097243d0090f3a0d715da
https://pubmed.ncbi.nlm.nih.gov/8973673
https://pubmed.ncbi.nlm.nih.gov/8973673
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 134(18)
The gene for the Wiskott-Aldrich syndrome, an X-linked immunodeficiency disease, has been mapped between the RFLP markers DXS7 and DXS14 on the short arm of the X-chromosome. Close linkage to these markers permits accurate carrier detection and prena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6a1f01121058aa5ac7de40c29927ff2
https://pubmed.ncbi.nlm.nih.gov/1971711
https://pubmed.ncbi.nlm.nih.gov/1971711
Publikováno v:
The Journal of Immunology. 137:1264-1269
Two hybridomas, derived by fusing mouse myeloma cells with spleen cells from a rat immunized with mouse mammary tumors, have been shown to produce antibodies that recognize cell surface antigens on mesenchymal cells in a variety of tissues. Evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb86c54862cf4ed9312c5f933bb9cf60
https://doi.org/10.4049/jimmunol.137.4.1264
https://doi.org/10.4049/jimmunol.137.4.1264
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 137(4)
Two hybridomas, derived by fusing mouse myeloma cells with spleen cells from a rat immunized with mouse mammary tumors, have been shown to produce antibodies that recognize cell surface antigens on mesenchymal cells in a variety of tissues. Evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e52ded1ede55ddeb3e53275125ce12a
https://pubmed.ncbi.nlm.nih.gov/2426359
https://pubmed.ncbi.nlm.nih.gov/2426359